Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Ambrian Capital PLC (AMBR)

  Print      Mail a friend

Tuesday 05 January, 2010

Ambrian Capital PLC

Ambrian Hires Leading Life Sc

RNS Number : 9992E
Ambrian Capital PLC
05 January 2010

Embargoed: 0700hrs, 5 January 2010

Ambrian Capital plc

Ambrian Hires Leading Life Sciences Equities Team

LONDON, 5 January 2010 Ambrian Partners Limited ("Ambrian"), a wholly-owned subsidiary of Ambrian Capital plc, has hired a leading life sciences equities team to be led by Julian Burn-Callander, a former Head of Equity Sales and founding partner of Code (now Nomura Code) Securities.

Prior to Nomura Code Securities Julian Burn-Callander, who has been in the equity markets for over thirty years, previously led Healthcare Specialist Sales at Panmure Gordon and was formerly Head of Equity Sales at SocGen. He will be joined by three highly experienced life sciences analysts, also founding partners of Code Securities: Paul Diggle, Mike Ward and Dr Chris Redhead. 

Paul Diggle, who has held a number of senior life sciences research positions including Head of Global Healthcare at S.G. Warburg, will initiate coverage of European large-cap pharmaceutical companies. Paul will work alongside Mike Ward, a specialist salesman and analyst who has held positions at both NatWest Markets and Deutsche Bank. Earlier in his career Mike spent a number of years at Glaxo Holdings and Sandoz (now Novartis).

Dr Chris Redhead has more than ten years experience providing investment research of small and mid-cap biotechnology, diagnostics and, more latterly, biologically-based cleantech companies. He has played a pivotal role in a range of significant fund-raisings and M&A transactions in the European life sciences sector and, together with Julian Burn-Callander, will form a strong team focused on small and mid-cap corporate client opportunities. 

Richard Chase, Managing Director of Ambrian Partners, commented,

"Ambrian Partners is seeking to build on its strong market positions in metals & mining, oil & gas and cleantech by hiring leading teams and individuals in certain key growth sectors. Julian and the team are very highly respected and are sure to make an important contribution as we seek to broaden the range of our specialist sectors. We are delighted to have recruited one of the top healthcare equities teams in the City."

- Ends -

For further press information please contact:

Richard Chase, Managing Director

Ambrian Partners Limited         

+44 (0)207 634 4700

Ben Simons or Charlotte Kirkham

M: Communications    

+44 (0)207 920 2340 / 2331

About Ambrian Capital plc 

Ambrian Capital (AIM: AMBR) is the holding company of Ambrian Partners Limited, Ambrian Commodities Limited and Ambrian Metals Limited. 

Ambrian Partners Limited is a focused investment bank known in the market today for its leading positions in the metals & mining, oil & gas and cleantech sectors. It provides corporate finance advice, equity research, sales and trading and market making services. Ambrian Partners has been ranked first in the AIM Basic Materials Sector in the Hemscott Advisers Rankings and was voted No. 1 for small and mid-cap mining in the Extel Survey of fund managers in 2009. Ambrian Partners is a member of the London Stock Exchange and is authorised and regulated by the Financial Services Authority.

For further information on Ambrian Capital, please visit:

This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t